Minnesota HF2930 allocates funds for ALS research, cancels a previous appropriation, and requires annual reporting.
Minnesota HF2930 provides funding for amyotrophic lateral sclerosis (ALS) research through competitive grants awarded by the Office of Higher Education. The bill allocates $396,000 for administrative costs and $19,604,000 for research grants in fiscal year 2024. It also appropriates $15,000,000 for a collaborative partnership between the University of Minnesota and the Mayo Clinic for ALS research in fiscal year 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.